Neurology News

After first-time stroke, comorbid PTSD was associated with increased risk for hospital readmission among Black veterans that was not observed among white veterans, researchers reported.

Artificial intelligence-based diagnostic tools may be valuable in accurately tracking myasthenia gravis symptoms and mitigating disease risk, according to a poster at the 2024 MDA Clinical & Scientific Conference.

Enzyme-replacement therapy may slow disease progression and improve motor function in children with Pompe disease, according to a poster from the 2024 Muscular Dystrophy Association Clinical & Scientific Conference.

As we discussed in our overview of the private equity, or PE, physician practice model, the buyer in an acquisition is often a PE-sponsored management services organization that purchases the nonclinical aspects of the practice’s business.

The FDA has declined to approve a new drug application for GA Depot 40 mg, a long-acting glatiramer acetate under investigation as a once-monthly injection for those with relapsing forms of multiple sclerosis, according to a press release

Completing medical education and training is a monumental achievement that can launch a successful lifetime career.

The FDA has granted breakthrough designation to MM-120 for the treatment of generalized anxiety disorder, according to a press release from MindMed.

Treatment with nusinersen was linked to increased motor function and reduction of the neurodegenerative biomarker neurofilament light chain in children with spinal muscular atrophy, according to interim results of a study.

Among adults with depression, risk for cardiovascular events was greater in women compared with men, regardless of age or obesity status, researchers reported in JACC: Asia.

WEST PALM BEACH, Fla. — Hispanic and Latino individuals with neuromyelitis optica spectrum disorder experienced improved outcomes with Uplizna compared with placebo, according to a poster from ACTRIMS 2024.